In a groundbreaking advancement in oncology, a new cancer drug is changing the future for patients diagnosed with advanced head and neck cancer. The immunotherapy drug, pembrolizumab, has shown remarkable
In a groundbreaking advancement in oncology, a new cancer drug is changing the future for patients diagnosed with advanced head and neck cancer. The immunotherapy drug, pembrolizumab, has shown remarkable